USD 2.4 billion
Allergy Immunotherapy Market Size, Share, Growth Analysis, By Treatment(Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT) (Tablets, Drops)), By Allergy(Allergic rhinitis, Allergic asthma, Others), By Distribution Channel(Offline (Hospital Pharmacy, Retail Pharmacy), Online), By Region - Industry Forecast 2024-2031
Report ID:
SQSG35I2019 |
Region:
Global |
Published Date: February, 2024
Pages:
242
|Tables:
92
|Figures:
76
Allergy Immunotherapy Market Insights
Allergy Immunotherapy Market size was valued at USD 2.07 billion in 2022 and is poised to grow from USD 2.26 billion in 2023 to USD 4.50 billion by 2031, growing at a CAGR of 9% in the forecast period (2024-2031).
Global Allergy Immunotherapy Market is segmented by Treatment, Allergy, Distribution Channel, and region. Based on Treatment, the market can be segmented into Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT) (Tablets, Drops). Based on Allergy, the market can be segmented into Allergic rhinitis, Allergic asthma, Others. Based on Distribution Channel, the market can be segmented into Online, Offline (Hospital Pharmacy, Retail Pharmacy). Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
According to the World Allergy Organization, approximately 10-30% of the global population is currently suffering from different kinds of allergies. Allergy is the body's immune system being overly sensitive to certain substances, such as a particular meal, pollen, fur, or dust. Allergies come in many forms, including those to food, dust, pollen, latex, medications, and others. In order to build antibodies against the allergens, the body is exposed to small amounts of allergies during allergy immunotherapy. Immunotherapy uses regular, low-dose exposure to particular allergens to help the body adjust to their presence, resulting in effective and prompt allergy treatment.
The primary factors propelling the global market for allergy immunotherapy are the expansion of industrialization and population, improvements in healthcare and medicine, and the launch of new immunotherapeutic medications. To increase the market share of the global allergy immunotherapy market, recent regulatory approvals, such as those for oral dissolvable tablets, are further enhanced.
US Allergy Immunotherapy Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Sublingual Immunotherapy (SLIT)
Fastest Growth
Sublingual Immunotherapy (SLIT)
Growth Rate
10.8% CAGR
Global Allergy Immunotherapy Market 2022-2028 ($ Bn)
Country Share for Europe Region- 2021 (%)
To get more reports on the above market click here to Buy The Report
Allergy Immunotherapy Market Segmental Analysis
The Global Allergy Immunotherapy Market is segmented based on treatment type, allergy type, distribution channel and region. Based on the Treatment Type, it is categorized into Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), and Oral Allergy Immunotherapy. Based on Allergy Type, it is categorized into Allergic Rhinitis, Asthma, Food Allergy, and Drug Allergy. Based on the Distribution Channel, it is categorized into Hospital Pharmacies, Retail Pharmacies and Drug Stores, and Online Pharmacies. Based on region, it is categorized into North America, Europe, Asia Pacific, The Middle East and Africa, and Latin America.
Allergy Immunotherapy Market Analysis by Treatment Type
On the basis of treatment type, the Sublingual Immunotherapy (SLIT) segment is projected to dominate the global allergy immunotherapy market over the forecast period. This is because it is the most efficient and popular type of allergen immunotherapy. Asthma, stinging insect hypersensitivity, and allergic rhinitis can all be effectively treated with this therapy. Additionally, SCIT has shown success in managing a variety of allergens. As a result, SCIT is more widely adopted than SLIT.
The segment for sublingual immunotherapy (SLIT) is anticipated to have the quickest CAGR throughout the projection period. For individuals who cannot receive allergy injections, SLIT is anticipated to become an essential option. SLIT pills that have received FDA approval and are currently available in the United States include Odactra, Grazax, Oralair, and Ragwitek. In the future, it is anticipated that liquid formulation will also be authorized for therapeutic use in the United States. This would accelerate the development of the SLIT market in the nation.
Allergy Immunotherapy Market Analysis by Distribution Channel
On the basis of distribution channel, the hospital pharmacy segment is expected to dominate the global allergy immunotherapy market over the forecast period. This is due to an increase in the number of patients seeking treatment for allergic disorders. In order to monitor and treat any negative responses, allergy injections are typically administered in medical facilities or doctor's offices. This accelerates the segment's growth even more. In order to increase the use of the therapy, medical facilities in Belgium have suggested setting up a national registry for allergen immunotherapy in hospitals and clinics. Additionally, after a few months of therapy, SLIT can be taken at home and the medications can be ordered online.
Global Allergy Immunotherapy Market By Treatment Type, 2021 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Allergy Immunotherapy Market Regional Insights
Based on the region, the European region currently dominates the global allergy immunotherapy market with respect to market share, and it is projected that it will continue to hold a sizable share of the market throughout the forecast period. Due to high awareness, increased financing for research and grants, medical reimbursement rules, the rise in the population with allergies, and other factors, Europe was reported to hold the largest share of the worldwide allergy immunotherapy market. According to the European Academy of Allergy and Clinical Immunology (EAACI), 20 percent of the population in the area currently experiences chronic food allergies, which affect over 150 million people.
Asthma and allergic rhinitis are the most prevalent allergens, affecting 100 million and 70 million individuals, respectively. Furthermore, according to the organization, by 2025, 50 percent of the people in Europe would suffer from allergies, opening up a huge market for allergy immunotherapy.
The prevalence of allergies in Europe is also becoming a significant economic burden as a result of the ensuing productivity losses in European countries. In response to these issues, European governments and organizations, such as EAACI, are trying to increase public awareness and urge for better medical education and treatments, which will help the market in the area flourish.
Global Allergy Immunotherapy Market By Geography, 2022-2028
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Allergy Immunotherapy Market Dynamics
Allergy Immunotherapy Market Drivers
- Increasing allergy cases to support the growth of allergy immunotherapy market: The rising prevalence of diverse allergies and the introduction of innovative sublingual immunotherapies in developing nations are the main drivers of market expansion for allergy immunotherapy. In the United States, allergies are the sixth most common chronic illness, costing more than USD 18 billion annually, and affect more than 50 million people, according to data from the American College of Allergy, Asthma & Immunology. Food allergies are becoming more common among both children and adults worldwide. Therefore, it is anticipated that the demand for innovative immunotherapies will be aided by the growing burden of allergic illnesses.
Allergy Immunotherapy Market Restraints
- The newest technology available on the market, the allergy immunotherapy, requires routine maintenance. Due to the particular need for professional staff in the process, the cost of routine maintenance is relatively expensive. The system's operational costs will consequently rise as a result of this. This is the key cause or element that is projected to seriously hamper the global allergy immunotherapy market. Additionally, there is a need to raise knowledge about this microgrid management system across the many businesses, since this factor's ignorance of new technical breakthroughs could prove to be a barrier to the market's expansion for these systems.
Request Free Customization of this report to help us to meet your business objectives.
Allergy Immunotherapy Market Competitive Landscape
Key players in the market are focusing on creating therapies for food allergies in particular by taking advantage of the rising prevalence of allergies. They are funding R&D initiatives in an effort to accomplish the same. To keep ahead of the curve, a number of firms are concentrating on creating new goods, including tablets and injections.
Allergy Immunotherapy Market Top Players Company Profiles
- ALK Abello
- Allergy Therapeutics
- Anergis SA
- ASIT biotech
- DBV Technologies
- HAL Allergy Group
- Hymenoptera Immunotherapy Group
- Immunomic Therapeutics, Inc.
- Laboratorios LETI
- Merck KGaA
- Novartis International AG
- Stallergenes Greer plc
- Tunitas Therapeutics, Inc.
- VentiRx Pharmaceuticals
- Biomay AG
- Genentech, Inc.
- GlaxoSmithKline plc
- Meda AB
- Pfizer Inc.
- Regeneron Pharmaceuticals, Inc.
Allergy Immunotherapy Key Market Trends
- Technology advancements in high-resolution analysis of rare cells in local tissues have led to the emergence of precise and reliable biomarkers for allergy immunotherapy monitoring.
- In addition to immunoglobulin and T-cell receptor transcript repertoires, genome-wide epigenetic alterations offer a source of novel biomarkers for allergy immunotherapy surveillance.
- Using advanced multi-parameter flow and mass cytometry, rare, antigen-specific immune cells can be quantified and immuno-phenotyped in order to track the allergy immunotherapy.
Allergy Immunotherapy Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyzes the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to the analysis, the global allergy immunotherapy market is currently led by countries in the European region, due to high awareness, and increased financing for research and grants in the region. Along with this, the sublingual immunotherapy (SLIT) segment is projected to dominate the global allergy immunotherapy market, due its high efficiency and popularity in the allergen immunotherapy market.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 2.07 billion |
| Market size value in 2031 | USD 4.50 billion |
| Growth Rate | 9% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Allergy Immunotherapy Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Allergy Immunotherapy Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Allergy Immunotherapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Allergy Immunotherapy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Allergy Immunotherapy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Allergy Immunotherapy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
